Understanding congenital bone marrow failure and related disorders through a national network
Official title: Potenziare la Gestione Clinica Delle CMF Attraverso Una Rete Nazionale Pediatrica e Dell'Adulto Basata su Dati Biologici e Genetici / Enhancing the Clinical Management of CMF Through a National Pediatric and Adult Network Based on Biological and Genetic Data
Run by Istituto Giannina Gaslini · NCT07877727 · Data updated 2026-11-12
This project tests whether people with rare inherited bone marrow failure syndromes or related conditions really have the underlying genetic causes, by collecting data and samples across multiple centers.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 28 Days to 65 Years |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | Istituto Giannina Gaslini Academic / other |
| Locations | 4 sites (Avellino and 3 other locations) |
| Status | Recruiting |
| Started | May 29, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | October 16, 2026 |
| Trial ID | NCT07877727 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Individuals diagnosed with Fanconi anemia, dyskeratosis congenita and other telomere biology disorders, congenital neutropenia, primary immune regulatory disorders, congenital amegakaryocytic thrombocytopenia, or acquired aplastic anemia, with or without paroxysmal nocturnal hemoglobinuria, and who can provide informed consent/assent.
✕Probably not a fit
Participants without the specified conditions or without available biospecimens or complete data may not directly benefit from the study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational, translational study enrolling patients with Fanconi anemia, dyskeratosis congenita, telomere biology disorders, congenital neutropenia, and related disorders to better define clinical and genetic features. It uses retrospective and prospective data collection and sample processing to identify disease-specific biomarkers and to clarify misdiagnoses between constitutional marrow failure and idiopathic cases. The goal is to characterize well-defined cohorts based on clinical history, manifestations, and immune findings, to improve understanding of underlying etiologies. No interventions are described in the protocol here; study activities focus on data collection, sample analysis, and observational correlations. The study is conducted across multiple Italian institutions under a national network.
Why it matters
Potential benefit: If successful, participants and future patients could receive more precise genetic and clinical classification, guiding prognosis and management.
How similar studies have gone: Previous research in CMF and related bone marrow failure conditions has shown that careful phenotyping and biomarker work can reveal underlying etiologies, though the integration of broader networks in this protocol represents a widening of scope.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with Fanconi anemia (FA), dyskeratosis congenita (DC) and other telomere biology disorders (TBD), congenital neutropenia (CN), primary immune regulatory disorders (PIRD), congenital amegakaryocytic thrombocytopenia (CAMT), and acquired aplastic anemia (AAA), with or without paroxysmal nocturnal hemoglobinuria (PNH). * Signed informed consent and/or assent obtained from the participant and/or their parents or legal guardians, as applicable. Exclusion Criteria: * Absence of signed informed consent and/or assent from the participant and/or their parents or legal guardians
Where it's running
-
AORN San Giuseppe Moscati Hematology and bone marrow Transplant Unit
Avellino, Italy Recruiting -
IRCCS Istituto Giannina Gaslini
Genova, Italy Recruiting -
Azienza Ospedaliera di Rilievo Nazionale Santobono Pausilipon Dipartimento di oncologia, ematologia e terapie cellulari
Naples, Italy Recruiting -
Università degli Studi di Verona Department of Engineering for Innovation Medicine
Verona, Italy Recruiting
Study contacts
- Study coordinator: Carlo Dufour
- Email: segrematologia@gaslini.org
- Phone: +3901056363528
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Reduced intensity bone marrow transplant for immune and bone marrow disorders
This study is testing a gentler type of bone marrow transplant to see if it can help people with immune and bone marrow disorders recover better and live longer.
-
Transplantation for inherited bone marrow failure disorders
This study is testing a new way to do stem cell transplants for people with inherited bone marrow failure disorders to see if it can help them recover faster and reduce the risk of infections without needing extra medication.
-
Using CD45RA Depleted Stem Cells to Prevent Infections After Transplant
This study is testing whether using special stem cells can help patients with high-risk leukemia recover their immune system faster and prevent infections after a stem cell transplant.
-
Understanding Squamous Cell Carcinoma in People with Fanconi Anemia
This study looks at how squamous cell carcinoma develops in people with Fanconi anemia to help catch it early and improve treatment options.
-
Investigating genetic factors in childhood cancer
This study is trying to find out if certain genes passed down in families can increase the risk of childhood cancer by looking at samples from kids who have had cancer and their relatives.
-
Investigation of genetics related to blood diseases
This study is trying to understand the genetics behind blood diseases by collecting samples and health information from people with these conditions and their family members.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.